MODERATOR :

Dirk Michels, Kirkpatrick & Lockhart Nicholson Graham LLP

Prior to practicing law in California, Mr. Michels had been an attorney in Hamburg, Germany for several years. His primary practice areas are international business transactions, primarily in corporate, financing, licensing and intellectual property matters. Mr. Michels represents domestic and foreign, especially German, entities doing business in the United States and Europe. His practice focuses on primarily small and mid-cap companies in the information technology, biotechnology, nanotechnology, and renewable energy industries.Mr. Michels' native language is German. In addition, he is fluent in English and speaks French.

SPEAKERS :

Dr. Tillson joined Cerus with considerable regulatory experience. She has a successful track record which includes submissions for HIV, malaria and CMV vaccines as well as overseeing several regulatory submissions and manufacturing inspections for class I, II, and III medical devices. Before joining Cerus she was the vice president of Regulatory Affairs at Onyx Pharmaceuticals, a biotech company developing oncology products. Prior to Onyx, Dr. Tillson was the vice president of Regulatory Affairs at Arriva Pharmaceuticals where she had responsibility for regulatory affairs, quality control and quality assurance, preclinical and clinical studies. She holds a bachelor's degree in honors biology, a master's degree in biology and a doctorate in cell biology from the University of Illinois.

Kevin Dwyer Managing Partner, VP, Regulatory Affairs (from Genentech) Pacific BioDevelopment

Kevin Dwyer is a co-founder and Vice President of Regulatory Affairs at Pacific BioDevelopment, LLC, one of the top consulting firms in the Biotech industry. Mr. Dwyer has over 25 years experience in the pharmaceutical industry, the last 15 years of which have been in Regulatory Affairs. His responsibilities include providing strategic guidance in the area Regulatory Affairs, with the primary focus on expediting the drug development process, performing critical reviews of IND and marketing applications (NDA, BLA), and coordinating and conducting pivotal meetings with the regulatory authorities in the US and Europe. He has been responsible for filing numerous INDs and marketing applications, both in CDER and CBER. Prior to Pacific BioDevelopment, Mr. Dwyer worked for Genentech, Inc., where he managed multiple investigational and marketed projects. Mr. Dwyer also worked as a Research Biologist for Monsanto Co., and St. Louis University Medical School. He has a B.A. in Biology from St. Louis University.

REGISTRATION.

French American Chamber of Commerce
info@faccsf.com
Tel: 415 442 4717 / Fax: 415 442 4621
703 Market Street, Suite 450 - San Francisco, CA 94103
 

Registration price valid until 5-days prior to the event date

Members

$20

Non-Members

$25 

$30 At the Door
 

Cancellations must be made 5-days prior to the event date

Any cancellation within a 5-day period of the scheduled date will not be refund

Name of guest will be kept at the door